Cargando…

Diabetes mellitus in elderly

Diabetes mellitus (DM) frequency is a growing problem worldwide, because of long life expectancy and life style modifications. In old age (≥60–65 years old), DM is becoming an alarming public health problem in developed and even in developing countries as for some authors one from two old persons ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chentli, Farida, Azzoug, Said, Mahgoun, Souad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673801/
https://www.ncbi.nlm.nih.gov/pubmed/26693423
http://dx.doi.org/10.4103/2230-8210.167553
_version_ 1782404811602264064
author Chentli, Farida
Azzoug, Said
Mahgoun, Souad
author_facet Chentli, Farida
Azzoug, Said
Mahgoun, Souad
author_sort Chentli, Farida
collection PubMed
description Diabetes mellitus (DM) frequency is a growing problem worldwide, because of long life expectancy and life style modifications. In old age (≥60–65 years old), DM is becoming an alarming public health problem in developed and even in developing countries as for some authors one from two old persons are diabetic or prediabetic and for others 8 from 10 old persons have some dysglycemia. DM complications and co-morbidities are more frequent in old diabetics compared to their young counterparts. The most frequent are cardiovascular diseases due to old age and to precocious atherosclerosis specific to DM and the most bothersome are visual and cognitive impairments, especially Alzheimer disease and other kind of dementia. Alzheimer disease seems to share the same risk factors as DM, which means insulin resistance due to lack of physical activity and eating disorders. Visual and physical handicaps, depression, and memory troubles are a barrier to care for DM treatment. For this, old diabetics are now classified into two main categories as fit and independent old people able to take any available medication, exactly as their young or middle age counterparts, and fragile or frail persons for whom physical activity, healthy diet, and medical treatment should be individualized according to the presence or lack of cognitive impairment and other co-morbidities. In the last category, the fundamental rule is “go slowly and individualize” to avoid interaction with poly medicated elder persons and fatal iatrogenic hypoglycemias in those treated with sulfonylureas or insulin.
format Online
Article
Text
id pubmed-4673801
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-46738012015-12-21 Diabetes mellitus in elderly Chentli, Farida Azzoug, Said Mahgoun, Souad Indian J Endocrinol Metab Review Article Diabetes mellitus (DM) frequency is a growing problem worldwide, because of long life expectancy and life style modifications. In old age (≥60–65 years old), DM is becoming an alarming public health problem in developed and even in developing countries as for some authors one from two old persons are diabetic or prediabetic and for others 8 from 10 old persons have some dysglycemia. DM complications and co-morbidities are more frequent in old diabetics compared to their young counterparts. The most frequent are cardiovascular diseases due to old age and to precocious atherosclerosis specific to DM and the most bothersome are visual and cognitive impairments, especially Alzheimer disease and other kind of dementia. Alzheimer disease seems to share the same risk factors as DM, which means insulin resistance due to lack of physical activity and eating disorders. Visual and physical handicaps, depression, and memory troubles are a barrier to care for DM treatment. For this, old diabetics are now classified into two main categories as fit and independent old people able to take any available medication, exactly as their young or middle age counterparts, and fragile or frail persons for whom physical activity, healthy diet, and medical treatment should be individualized according to the presence or lack of cognitive impairment and other co-morbidities. In the last category, the fundamental rule is “go slowly and individualize” to avoid interaction with poly medicated elder persons and fatal iatrogenic hypoglycemias in those treated with sulfonylureas or insulin. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4673801/ /pubmed/26693423 http://dx.doi.org/10.4103/2230-8210.167553 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Review Article
Chentli, Farida
Azzoug, Said
Mahgoun, Souad
Diabetes mellitus in elderly
title Diabetes mellitus in elderly
title_full Diabetes mellitus in elderly
title_fullStr Diabetes mellitus in elderly
title_full_unstemmed Diabetes mellitus in elderly
title_short Diabetes mellitus in elderly
title_sort diabetes mellitus in elderly
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673801/
https://www.ncbi.nlm.nih.gov/pubmed/26693423
http://dx.doi.org/10.4103/2230-8210.167553
work_keys_str_mv AT chentlifarida diabetesmellitusinelderly
AT azzougsaid diabetesmellitusinelderly
AT mahgounsouad diabetesmellitusinelderly